Jefferies Group's FOLD Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 165,485 shares of Amicus Therapeutics, Inc. (FOLD) worth $2.36 M, representing 0.01% of the portfolio. First purchased in 2023-Q2, this short-term holding has been held for 8 quarters.
Based on 13F filings, Jefferies Group has maintained this position in FOLD for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 187,897 shares. Largest reduction occurred in Q3 2025, reducing 58,315 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Amicus Therapeutics (FOLD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amicus Therapeutics (FOLD) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2023 | +92,285 | New Buy | 92,285 | $12.56 |
| Q3 2023 | -38,512 | Reduce 41.73% | 53,773 | $12.16 |
| Q4 2023 | -24,279 | Reduce 45.15% | 29,494 | $14.19 |
| Q1 2024 | -29,494 | Sold Out | 0 | $0.00 |
| Q1 2025 | +187,897 | New Buy | 187,897 | $8.16 |
| Q2 2025 | +35,903 | Add 19.11% | 223,800 | $5.73 |
| Q3 2025 | -58,315 | Reduce 26.06% | 165,485 | $7.88 |
Jefferies Group's Amicus Therapeutics Investment FAQs
Jefferies Group first purchased Amicus Therapeutics, Inc. (FOLD) in Q2 2023, acquiring 92,285 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Amicus Therapeutics, Inc. (FOLD) for 8 quarters since Q2 2023.
Jefferies Group's largest addition to Amicus Therapeutics, Inc. (FOLD) was in Q1 2025, adding 187,897 shares worth $1.53 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 165,485 shares of Amicus Therapeutics, Inc. (FOLD), valued at approximately $2.36 M.
As of the Q4 2025 filing, Amicus Therapeutics, Inc. (FOLD) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Amicus Therapeutics, Inc. (FOLD) was 223,800 shares, as reported at the end of Q2 2025.